Financial News
Amneal Pharmaceuticals, Inc. - Class A Common Stock (NY:AMRX)
All News about Amneal Pharmaceuticals, Inc. - Class A Common Stock










Amneal to Report Third Quarter 2023 Results on November 7, 2023
October 05, 2023
Via Business Wire

Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
September 06, 2023
Via Business Wire

Amneal Receives First Product Approval in China
September 06, 2023
Via Business Wire

Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
September 06, 2023
Via Business Wire


Via Business Wire






Amneal Reports Second Quarter 2023 Financial Results
August 04, 2023
Via Business Wire









Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.